Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment
The recent launching of the visionary Precision Medicine Initiative by President Barack Obama seeks to integrate individual variability in genes, environment, and lifestyle for personalized disease treatment and prevention. As the second most common cause of death in the US after heart disease, cancer remains one of the most fatal diseases. Oncology drug discovery is therefore at the forefront of the initiative. The initiative recognizes the issue of drug resistance and seeks to develop solutions.
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Worapol Ngamcherdtrakul, David J. Castro, Shenda Gu, Jingga Morry, Moataz Reda, Joe W. Gray, Wassana Yantasee Tags: New Drugs Source Type: research
More News: American Health | Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Cardiology | Environmental Health | Genetics | Heart | Heart Disease | HER2 | Obama